Literature DB >> 17926980

Prevalence of nosocomial infection in Thailand 2006.

Somwang Danchaivijitr1, Tepnimit Judaeng, Siriporn Sripalakij, Kakanang Naksawas, Tanarak Plipat.   

Abstract

OBJECTIVE: To study the prevalence of nosocomial infection (NI). MATERIAL AND
METHOD: A point prevalence study was done in 20 hospitals across the country in August 2006.
RESULTS: The present study was done in 20 hospitals: three university, five regional, five provincial, and seven other hospitals. 9,865 patients were included Male and female patients were almost equal in number with an average age of 42.7 years. The NI proportion was 6.5%, 7.0% in male and 5.9% in female patients. The prevalence rate of NI was highest in university and other hospitals (7.6%), followed by provincial (6.0%), and regional hospital (4.9%). There were two hospitals, one regional and one other hospital with NI prevalence rates over 10%. All three university hospitals had NI exceeding 7%. The infection rate was highest in ICU (22.6%), followed by surgical (6.8%), medical and orthopedic (6.7% each) departments. The commonest site of NI was lower respiratory tract (36.1%) followed by urinary tract (25.5%). Causative organisms were identified in 70.8% of all sites of infection and over 63% were by bacteria. Gram-negative bacteria were responsible for 70.2% and gram-positive bacteria for 19.9% of all pathogens. Pseudomonas aeruginosa, Klebsiella spp., Acinetobacter baumannii, MRSA, and enterococci were the leading bacterial isolates. At the time of the present study, 47.0% of patients were receiving antimicrobials. Cephalosporins, penicillins, and aminoglycosides were most commonly used
CONCLUSION: The prevalence rate of NI in Thailand in 2006 was 6.5%, similar to previous studies. Changes in NI rates in certain hospitals, even though subtle, need additional studies to improve the efficacy of NI control.

Entities:  

Mesh:

Year:  2007        PMID: 17926980

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  10 in total

1.  Prevalence of healthcare-associated infections in acute care hospitals in Jacksonville, Florida.

Authors:  Shelley S Magill; Walter Hellinger; Jessica Cohen; Robyn Kay; Christine Bailey; Bonnie Boland; Darlene Carey; Jessica de Guzman; Karen Dominguez; Jonathan Edwards; Lori Goraczewski; Teresa Horan; Melodee Miller; Marti Phelps; Rebecca Saltford; Jacquelyn Seibert; Brenda Smith; Patricia Starling; Bonnie Viergutz; Karla Walsh; Mobeen Rathore; Nilmarie Guzman; Scott Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2012-01-12       Impact factor: 3.254

2.  Train-the-Trainers in hand hygiene: a standardized approach to guide education in infection prevention and control.

Authors:  Ermira Tartari; Carolina Fankhauser; Sarah Masson-Roy; Hilda Márquez-Villarreal; Inmaculada Fernández Moreno; Ma Luisa Rodriguez Navas; Odet Sarabia; Fernando Bellissimo-Rodrigues; Marcela Hernández-de Mezerville; Yew Fong Lee; Mohammad Hassan Aelami; Shaheen Mehtar; Américo Agostinho; Liberato Camilleri; Benedetta Allegranzi; Daniela Pires; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2019-12-30       Impact factor: 4.887

3.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

4.  Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand.

Authors:  Piyatip Khuntayaporn; Preecha Montakantikul; Piroon Mootsikapun; Visanu Thamlikitkul; Mullika Traidej Chomnawang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-09-13       Impact factor: 3.944

5.  Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia.

Authors:  Rujipas Sirijatuphat; Kantarida Sripanidkulchai; Adhiratha Boonyasiri; Pinyo Rattanaumpawan; Orawan Supapueng; Pattarachai Kiratisin; Visanu Thamlikitkul
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

6.  Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran.

Authors:  Afsaneh Vazin; Motahare Mahi Birjand; Masoud Darake
Journal:  Drug Healthc Patient Saf       Date:  2018-04-05

7.  Train-the-Trainers in hand hygiene: a standardized approach to guide education in infection prevention and control.

Authors:  Ermira Tartari; Carolina Fankhauser; Sarah Masson-Roy; Hilda Márquez-Villarreal; Inmaculada Fernández Moreno; Ma Luisa Rodriguez Navas; Odet Sarabia; Fernando Bellissimo-Rodrigues; Marcela Hernández-de Mezerville; Yew Fong Lee; Mohammad Hassan Aelami; Shaheen Mehtar; Américo Agostinho; Liberato Camilleri; Benedetta Allegranzi; Daniela Pires; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2019-12-30       Impact factor: 4.887

8.  Trends of Healthcare-associated Infections in a Tuinisian University Hospital and Impact of COVID-19 Pandemic.

Authors:  Hela Ghali; Asma Ben Cheikh; Sana Bhiri; Selwa Khefacha; Houyem Said Latiri; Mohamed Ben Rejeb
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

9.  Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of Acinetobacter baumannii and Pseudomonas aeruginosa in an Academic Medical Center in Thailand.

Authors:  Taniya Paiboonvong; Phatchareeporn Tedtaisong; Preecha Montakantikul; Sarun Gorsanan; Woraphot Tantisiriwat
Journal:  Antibiotics (Basel)       Date:  2022-01-23

10.  Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys.

Authors:  Geoffrey Taylor; Denise Gravel; Anne Matlow; Joanne Embree; Nicole LeSaux; Lynn Johnston; Kathryn N Suh; Michael John; John Embil; Elizabeth Henderson; Virginia Roth; Alice Wong
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-21       Impact factor: 4.887

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.